Investment Summary |
|
|---|---|
| Date | 2017-12-17 |
| Target | Lantheus Medical Imaging |
| Sector | Medical Products |
| Sellers(s) | Bristol-Myers Squibb |
| Deal Type | Divestiture |
| Deal Value | 525M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1887 |
| Sector | Life Science |
| Employees | 34,100 |
| Revenue | 48.3B USD (2024) |
Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Bristol-Myers Squibb was incorporated in 1887 and is based in Princeton, New Jersey.
| DEAL STATS | # |
|---|---|
| Overall | 9 of 13 |
| Sector: Medical Products M&A | 4 of 5 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 8 of 8 |
| Year: 2017 M&A | 1 of 1 |
| Size (of disclosed) | 4 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-08-03 |
IFM Therapeutics
Boston, Massachusetts, United States IFM Therapeutics is a biotech company focused on developing therapies that modulate novel targets in the innate immune system to treat cancer, autoimmunity and inflammatory disorders. IFM Therapeutics is based in Boston, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2018-10-08 |
Upsa
France Upsa is a provider of an over-the-counter drugs business. Upsa is based in France. |
Sell | - |
